OXFORD, Miss. – As part of its roster of scientific research, the University of Mississippi School of Pharmacy will join technology group STEERLife in a four-year collaborative project to revamp pharmaceutical drug development and manufacturing
STEERLife designs, creates and implements technology and processes for improving the quality of pharmaceutical products. The company approached Narasimha Murthy, professor of pharmaceutics and drug delivery, and Michael Repka, professor and chair…
August 20, 2015
“We are very excited to commemorate this milestone in our program,” said Ed Brunson, course director. “The success of the Hands-on Course in Tablet Technology has been outstanding. With 20 to 40 participants per course, our reach has greatly expanded since the first class in 1998.”
February 26, 2013
A University of Mississippi pharmacy professor has been elected a fellow of the American Association of Pharmaceutical Scientists for his pioneering work on hot-melt extrusion, a technology that is shaping advanced manufacturing in the pharmaceutical industry.
Michael A. Repka, professor and chair of pharmaceutics, was nominated for fellowship status by a retired pharmaceutical industry executive.
December 14, 2012
An innovative delivery method for tetrahydrocannabinol, the main psychoactive constituent of Cannabis, is being developed at the University of Mississippi.
School of Pharmacy faculty members Michael A. Repka, Soumyajit Majumdar and Mahmoud A. ElSohly have developed a transmucosal THC patch to overcome problems related to taking the drug in pill form. The patch is administered above the gum line.
May 5, 2012
Pharmaceutics International Inc. has made a gift to the University of Mississippi to support pharmaceutical education for graduate students and create a center devoted to research related to hot melt extrusion and other pharmaceutical processing technologies.
The Pii Center for Pharmaceutical Technology will collaborate with private industry, government agencies and other universities to conduct research aimed at developing novel, cost-effective, patient-friendly and efficacious formulations for delivering new and existing pharmaceutical products.